Screening for Fabry Disease in Patients with Chronic Kidney Disease | Zendy

Jason G. Andrade | Zendy; Paula J. Waters | Zendy; Rajvir Singh | Zendy; Adeera Levin | Zendy; Bee-Chin Toh | Zendy; Hilary Vallance | Zendy; Sandra Sirrs | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Screening for Fabry Disease in Patients with Chronic Kidney Disease

Author(s) -

Jason G. Andrade,

Paula J. Waters,

Rajvir Singh,

Adeera Levin,

Bee-Chin Toh,

Hilary Vallance,

Sandra Sirrs

Publication year - 2007

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02490607

Subject(s) - medicine , lymphoma , lymphoid hyperplasia , pathology , immunophenotyping , cytology , biopsy , follicular hyperplasia , b cell , follicular lymphoma , antibody , immunology , flow cytometry

Fabry disease is a progressive X-linked disorder of glycosphingolipid metabolism that typically presents in childhood and progresses to heart failure and renal failure in adulthood. This study sought to determine the prevalence of Fabry disease in a multiethnic male chronic kidney disease population, involving dialysis-dependent, non-dialysis-dependent, and transplant patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research